Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative
Open Access
Abstract
Scutellarin (1) has been widely used to treat acute cerebral infarction in clinic, but poor aqueous solubility decreases its bioavailability. Interestingly, scutellarin (1) could be metabolized into scutellarein (2) in vivo. In this study, a sulfonic group was introduced at position C-8 of scutellarein (2) to enhance the aqueous solubility of the obtained derivative (3). DPPH (1,1-diphenyl-2-picrylhydrazyl)-radical scavenging ability and antithrombic activity were also conducted to determine its bioactivity. The result showed that scutellarein derivate (3) could be a better agent for ischemic cerebrovascular disease treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81274058, 21302225)
- China Scholarship Council (201407060046)
- Natural Science Foundation of Jiangsu Province (BK20151563)
- 333 High-level Talents Training Project Funded by Jiangsu Province, Six Talents Project Funded by Jiangsu Province (2013-YY-010)
- Program for Excellent Talents in School of Pharmacy of Nanjing University of Chinese Medicine (15ZYXET-1)
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (ZDXMHT-1-13)
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and Project Funded by the Flagship Major Development of Jiangsu Higher Education Institutions (PPZY2015A070)
This publication has 29 references indexed in Scilit:
- Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activityBiochemical and Biophysical Research Communications, 2017
- Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathwayInternational Immunopharmacology, 2016
- Scutellarin attenuates vasospasm through the Erk5-KLF2-eNOS pathway after subarachnoid hemorrhage in ratsJournal of Clinical Neuroscience, 2016
- Sustained release and enhanced bioavailability of injectable scutellarin-loaded bovine serum albumin nanoparticlesInternational Journal of Pharmaceutics, 2014
- StrokeThe Lancet, 2008
- Inhibitory effect of Erigeron breviscapus extract and its flavonoid components on GABA shunt enzymesPhytomedicine, 2008
- Effects of Erigeron breviscapus ethanol extract on neuronal oxidative injury induced by superoxide radicalFitoterapia, 2005
- Well-Being After Stroke in Canadian SeniorsStroke, 2002
- Handicap After Stroke: How Does It Relate to Disability, Perception of Recovery, and Stroke Subtype?Stroke, 2002
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 1997